Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter

Abstract

<p class="first" id="P1">The human immunodeficiency virus type 1 (HIV-1) transactivator of transcription (Tat) protein functions both intracellularly and extracellularly. Intracellularly the main function is to enhance transcription of the viral promoter. However, this process only requires a small amount of intracellular Tat. The majority of Tat is secreted through an unconventional mechanism by binding to phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P ₂), a phospholipid in the inner leaflet of the plasma membrane that is required for secretion. This interaction is mediated by the basic domain of Tat (residues 48–57) and a conserved tryptophan (residue 11). After binding to PtdIns(4,5)P ₂, Tat secretion diverges into multiple pathways, which we categorized as: oligomerization-mediated pore formation, spontaneous translocation, and incorporation into exosomes. Extracellular Tat has been shown to be neurotoxic and toxic to other cells of the CNS and periphery, able to recruit immune cells to the CNS and cerebrospinal fluid, and alter the gene expression and morphology of uninfected cells. The effects of extracellular Tat have been examined in HIV-1-associated neurocognitive disorders (HAND), however, only a small number of studies have focused on the mechanisms underlying Tat secretion. In this review, the molecular mechanisms of Tat secretion will be examined in a variety of biologically relevant cell types. </p><p id="P2">After the initial binding of residue 11 (light grey), a conserved tryptophan, inserts into the plasma membrane and stabilizes the interaction with PtdIns(4,5)P ₂. The specific region of PtdIns(4,5)P ₂ involved in this interaction is unknown. 3. After the interaction occurs, Tat is translocated extracellularly, but the exact process has yet to be elucidated. <b>C)</b> The process by which Tat is incorporated into exosomes is poorly understood. 1. Tat may bind to PtdIns(4,5)P ₂ at the exosomal membrane, such as during the formation of multiple vesicular bodies. 2. During invagination of the exosome, Tat may interact with HIV-1 TAR (red) and be incorporated at a higher rate. 3. During invagination of the exosome, Tat may interact with host proteins (yellow) and be incorporated at a higher rate. (INT, Intracellular; EXT, Extracellular; EXO, Exosome) </p><p id="P3"> <div class="figure-container so-text-align-c"> <img alt="" class="figure" src="/document_file/c81481ee-df65-42a1-b518-5b17fa49b036/PubMedCentral/image/nihms963990u1.jpg"/> </div> </p>